Clinical Trial Update: Safety of TACE With Oxaliplatin, Irinotecan and Raltitrexed for Refractory Colorectal Cancer Liver Metastasis

View source ↗

Summary

A clinical trial update evaluating the safety of transarterial chemoembolization using oxaliplatin, irinotecan, and raltitrexed for refractory colorectal cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• Raltitrexed (Raltitrexed)

Snippet

Sponsor: Fudan University | Conditions: Colon Cancer Liver Metastasis | Status: UNKNOWN